Aptera Motors prices $6M registered direct offering with concurrent warrant private placement
On November 10, 2026, Aptera Motors, a solar electric vehicle developer, agreed with institutional investors to sell about 3.43 million Class B shares at $1.75 each in a registered direct offering. A concurrent private placement adds warrants for the same number of shares at a $2.05 exercise price, exercisable only after stockholder approval. Gross proceeds of about $6 million are earmarked for vehicle validation, manufacturing readiness and production planning, with closing expected around November 11, 2026. The company is not a pharma business, so the item is of limited relevance to life-sciences readers.
Company's press release (SEC filing): Aptera Motors Corp ↗
Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.
IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M
Femasys Q3 2026: $30M private placement closed; U.S. sales flat, total sales fall 44.5% to $404,597
Mingteng International, an automotive mold maker, prices $2.00/share registered direct offering with pre-funded warrants
Organigram to acquire Aurora Cannabis for about C$561M, backed by BAT private placement and ATB credit facilities
Windward Bio prices Nasdaq IPO of 10.3 million shares at $17, targeting $225 million in gross proceeds
